wk 1- CVD Flashcards

1
Q

what age do people need to be screened for CVD risk and recommended times going forward

A

45+ every 5 years

35years for ASTI people

people regarded as high risk already are
-CVD patients
-DM if >60yrs
-CKD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

modifiable and non modifiable risk factors of CVD

A

MOD:
hypertension
dyslipideamia
smoking
obesity
sedentary
alcohol
DM

NON MOD:
-family history
gender (male)
age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

management on how to modify risk factors and dislipidaemia

A

lifestyle changes of

diet-
1. consume a whole foods diet (mederteranian style),
2. limit foods containing saturated and trans fats
3. limit salts
4 limit alcohol consumption (2standard per day or less)
5. add plant sterol rich foods (milk, cheese, margarine)

physical activity-
minimum 30mins of moderate activity per day

weight-
limit energy intake and increase energy output, goal is BMI less than 25

smoking-
smoking cessation or nicotine replacement therapy

AND

medications-
lipid lowering medication for
1. previous ASCVD, high risk CVD
2. moderate risk CVD after 3-6months of lifestyle changes not helping with also a family history of premature CVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

medication choices and MOA for dislipidaemia

A
  1. statin -1st line
    MOA: HMG CoA reductase inhibitors, which reduce cholesterol synthesis in liver
  2. ezetimbe
    MOA: decreases choelsterol absoprtion in small intestine
  3. fibrates
    MAO: complex
  4. fibrates and omega 3
    -used for hypertrigylceridaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

define dyslipidaemia, what serious pathology is it linked to, what are primary/secondary differences

A

derangement of plasma lipid levels (cholesterol and or triglycerides)

associated with atherosclerosis, PAD, CAD, STROKE- serious pathology that involves blockage of an artery

primary: gene mutations which result in
1. excessive production
2. decreased clearance of LDL/trigylcerides
3. decreased production, increased clearance of HDL

secondary: low levels of activity, excessive dietary intake of sat fats, cholesterol and trans fats

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

different types of dislipidaemia and ranges

A

hypercholesterolaemia
1. total Cholestero is 5.5mmol/L or more
2. and or LDL is 3.5mmol/l or more

hypertriglyceriaemia
1. triglycerises is 2mmol/L or more

mixed dyslipidaemia
1. both tri and cholesterol elevated (2mmol/L or more and 5.5mmol/l or more)

LOW HDL
1. HDL is less than 1mmol/L for men and 1.3 for women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

patho of ASCVD/ lipid metabolism

A
  1. lipids (cholesterol and triglycerides) are insoluble in blood therefore theyre transported within lipoproteins
  2. Lipids (now monoglycerides, fatty acids and cholesterol) leave micelles and reassemble into chylomicrons which transport lipids around the body

3.liver synthesis lipoproteins to transport cholesterol and cholesterol

-LDL is either cleared by liver or taken up into vascular endotheliium
-HDL are initially cholesterol free and transport cholesterol from tissues to other cells or liver for clearance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

dyslipidaemia/ ASCVD symptoms

A

dislipideamia is usually asymptomatic and manifests as

heart attack
stroke
or picked up on health screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

hypertrigylceride symptoms

A

acute pancreaitis with severe upper abdominal pain which may radiate to back
nausea
vomiting
pallor
diaphoresis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

high levels of LDL symptoms

A

corneal arcus (deposits of lipids around corneal margin of eye

tendinous xanthomata

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

management of dyslipidaemia

A
  1. lifestyle changes
    activity 30mins - decreases TG and increases HDL
    diet- mediteranian and low in sat and trans fats
  2. medications when
    - patient has ASCVD or
    - high CVD risk or
    - 3-6months with lifestyle changes at mod risk and fam history of premature CVD

medication is typically lifelong so other causes need to be ruled out

for high LDL cholesterol
1. statin
2. ezetimbe
3. fibrate

for hypertrigylceridaemia
1. fibrate and omega 3 fatty acids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

define hypertension and range classification, primary and secondary causes

A

sustained elvation of BP

systolic BP >140mmHG
diastolic BP >90mmhg
or both

primary: most common due to
1. activation of sympathetic nervous system,
2. RAAS overactivity,
3. vasodilator deficiency in endothelium

secondary: due to
1. primary aldosteronism or
2. chronic kidney disease or
3. other diseases/conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

hypertension symptoms

A

asymptomatic usually until complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

diagnosisng hypertension and grades, and medical emergency

A

calibrated sphygmomanometer

grade 1: 140/90, ambulatory or home monitoring should be used to determine BP, might be white coat
grade 2- 160/100
grade 3: 180/110

> 220/140 is medical emergency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hypertension management

A
  1. lifestyle modifications
    cease smoking
    regular exercise
    reduce alcohol and salt
    better diet
    lose weight
    manage obstructive sleep aponea
  2. medications
    starts when
    - BP 160/100
    -mod-high CVD risk and 140/90 BP

antihypertensives
1. ACE/ARB/CCB/BB/thiazide diuretic- first line
2. after 3 months, not controlled, add a second
3.” 3rd, if not signs of secondary hypertension causes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

define coronary artery disease

A

Impairment of blood flow through the coronary arteries, which supply
blood to the heart muscle (myocardium)

can be
angina OR
myocardial infarction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

patho of ACS

A
  1. Athersclerosis caused by uptake of lipids in vasuclar endothelium of the coronary arteries leads to progressive narrowing
    and reduction in blood flow
  2. stabiliy of the plaque influences the presentation
    - stable angina
    -rupture and thrombosis results in ACS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

signs of stable angina and ACS

A

stable: chest pain that may radiate to left arm, felt under sternum triggered by exertion and settles with rest

ACS: same chest pain present at rest and increased in frequency/severity/duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

testing for CAD (diagnosing)

A

ECG
cardiac markers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

management of CAD- stable

A
  1. life style modifications
    -activity
    -diet
    -weight loss
    -smoking cessation
    -alcohol cessation
  2. medications
    -antiplatelets
    -statins
    -ACE/BB/CCB
    -nitrates for angina
  3. surgery
    for patients with persistent symptoms and maximum medical intervention
    - coronary artery bypass grafting
    -PCI
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

management of ACS

A
  1. hospital
    -oxygen
    -aspirin
    -nitrates
    -morphine
    -BB
    -anticoagulants
  2. STEMI OR NSTEMI
    -STEMI: urgent coronary angiography and artery bypass or thrombolysis
    -NSTEMI: prompt bypass

patients with stent need dual antiplatelet for 12 months following then aspirin alone lifelong

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

complications of myocardial infarction

A
  • Electrical (arrhythmia, conduction disturbances)
  • Mechanical (heart failure, myocardial rupture)
  • Thrombotic (recurrent coronary ischaemia, mural thrombosis)
  • Inflammatory (pericarditis, effusion, joint pain)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is heart failure

A

Syndrome of ventricular dysfunction

Typically secondary to CAD but can occur due to many heart conditions

24
Q

Diagnosis of HF

A

ECG
Chest x ray
plasma BNP levels
clinical features

25
Q

Management of HF

A
  1. Manage causes
  2. Fluid and salt restriction
  3. Activity
  4. Medications (ACE/BB/LOOP/DEFIBRILLATORS/aldosterone antagonists)
26
Q

median survival after diagnosis of hF

A

3-4 YEARS

27
Q

What is AF

A

Rapid and irregular arrhythmia of the hearts upper chambers

Typically secondary to heart conditions/diseases

28
Q

Symptoms of AF

A

Palpitations
Fatigue
Breathlessness

may be asymptomatic

29
Q

serious Complication of AF

A

Formation of atrial thrombus which embolisms and causes stroke

30
Q

Management of AF

A
  1. Rhythm control (electrical or chemical)- BB/CCB
  2. Rate control with anticoagulant
31
Q

Chest pain red flags

A
  1. Crushing/heavy/tearing chest pain -ACS
  2. Shortness of breath- reduced blood flow to lungs
  3. Loss of consciousness -reduced perfusion
  4. Racing heart rate or low BP - significant disease
32
Q

What is peripheral arterial aneurysms

A

Abnormal dilations of peripheral arteries caused by weakening of arterial wall (athleroscelrosis)

Usually involves popliteal artery

33
Q

Symptoms and diagnosis of popliteal arterial aneurysm

A

Asymptomatic

Imaging- often US, CT OR MRA

34
Q

Management of popliteal arterial aneurysm

A

Rupture is rare so unless symptomatic, repair isn’t necessary

35
Q

what usually accompanies pAA

A

abdominal aortic anuerysm

but high risk of death for repair so only worked on if high risk of rupture

36
Q

What is PAD, who is it more common in, what is it associated with

A

Atherosclerosis of an extremity resulting in ischaemia, more common in males

CAD is the cause of death in majority of patients with PAD

37
Q

Symptoms / clinical features of PAD

A

Some asymptomatic

  • intermittent claudication: pain on exertion, relieved by rest

-rest pain, particularly when legs are elevated

  • ulceration: painful punched out ulcers on bony promiences
  • thin, pale skin with loss of hair
    -cold extremities
    -diminished or absent pulses
38
Q

Diagnosis of PAD

A
  • ABI /TPI
  • Doppler
    -angiography
39
Q

ABI readings and PAD

A
  • 0.7-0.9 - mild PAD
  • 0.4-0.7 - moderate PAD
  • <0.4 - severe PAD
  • > 1.3 - arterial calcification
40
Q

Management of PAD

A
  1. Manage risk factors/conditions
  2. Exercise - Walking program
  3. Preventative foot care
  4. Medication (anti platelet, ACE, statin, etc)
  5. Per cutaneous transluminal angioplasty (PTA): non surgical method for dilating occlusions
  6. Surgery: revascularisation with bypass or endarterectomy
41
Q

Peripheral venous disease (chronic venous insufficiency)

A

Impaired venous return due to hypertension which is caused by venous valve damage (DVT/trauma/age/genetic)

42
Q

Symptoms of PVD (CVI)

A

Heavy achy legs
Worse when standing
Worse when static
Swelling
Skin changes

43
Q

Diagnosis of PVD (cvi)

A

Venous doppler

44
Q

Management of PVD (CVI)

A
  1. Elevation, compression, wound care
  2. Surgery is inefficient as chronic venous insufficiency is recurrent
45
Q

PVD Varicose veins, who is it common in

A

Dilated superficial veins, resulting from venous vavlular insufficiency

More common in females bc oestrogen weakens valves, pregnancy increases venous pressures

46
Q

Management of Varicose veins

A
  1. Compression stockings
  2. Surgery
    But treatment has high risk of recurrence
47
Q

Deep vein thrombosis DVT

A

Clotting of blood in a deep vein which results in impaired venous return, endothelial dysfunction and hypercoagulability

Also known as the virchows triad

48
Q

Risk factors for DVT (virachows triad

A
  1. Altered blood flow (surgery, immobility, dehydration, obesity)
  2. Endothelial injury (previous DVT, smoking, trauma)
  3. Hypercoagulability (malignancy, pregnancy, hypercoagulability disorders like factor V Leiden
49
Q

DVT clinical features

A

calf pain
tenderness/swelling/warmth
palpation of thrombosed veins and superficial venous dilation

50
Q

diagnosis of DVT

A

venous doppler US

51
Q

Complications of DVT

A
  1. Pulmonary embolism
  2. Post thrombotic syndrome
52
Q

DVT management

A
  1. Compression stockings- for atleast 18 months
  2. Anticoagulants
53
Q

What is superficial thrombophlebitis

A

Blood clot in superficial veins

above the knee, At risk of DVT

54
Q

management of superficial thrombophlebitis

A

below knee
1. compression
2. NSAIDS

above knee
1. anticoagulants (heparin)

55
Q

is CVD the leading cause of death in aus

A

yes